Clinical and molecular landscape of ALS patients with SOD1 mutations: Novel pathogenic variants and novel phenotypes. a single ALS center study

29Citations
Citations of this article
44Readers
Mendeley users who have this article in their library.

Abstract

Mutations in the copper zinc superoxide dismutase 1 (SOD1) gene are the second most frequent cause of familial amyotrophic lateral sclerosis (ALS). Nearly 200 mutations of this gene have been described so far. We report all SOD1 pathogenic variants identified in patients followed in the single ALS center of Lyon, France, between 2010 and 2020. Twelve patients from 11 unrelated families are described, including two families with the not yet described H81Y and D126N mutations. Splice site mutations were detected in two families. We discuss implications concerning genetic screening of SOD1 gene in familial and sporadic ALS.

Cite

CITATION STYLE

APA

Bernard, E., Pegat, A., Svahn, J., Bouhour, F., Leblanc, P., Millecamps, S., … Mouzat, K. (2020). Clinical and molecular landscape of ALS patients with SOD1 mutations: Novel pathogenic variants and novel phenotypes. a single ALS center study. International Journal of Molecular Sciences, 21(18), 1–11. https://doi.org/10.3390/ijms21186807

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free